Astellas will continue development of DAX-044, which is expected to enter Phase I in 2027. Credit: Lightspring / Shutterstock.com. Astellas Pharma has inked a billion-dollar licensing deal with ...
Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results